Strategies to formulate lipid-based drug delivery systems

American Pharmaceutical Review

Volumn 14, Issue 4, 2011, Pages 84-92

  Cannon, John B ^a  

^a TRINITY EVANGELICAL DIVINITY SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; CALCITRIOL; CYCLOSPORIN; GRANULAC; LIPID; LOPINAVIR; PARICALCITOL; PEARLITOL; RAPAMYCIN; RITONAVIR; TIPRANAVIR; UNCLASSIFIED DRUG;

DIGESTION; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; EMULSION; HUMAN; HYDROPHILICITY; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SOLUBILIZATION; THERMODYNAMICS;

EID: 79959923845     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Water - Insoluble Drug Formulation, 2nd edition, Liu, R., Ed., CRC Press, Boca Raton FL (2008); p.1.
2. Constantinides, P.P. (1995). Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects. Pharm. Res. 12: 1561-1572.
3. Strickley, R.G. (2004) Solubilizing Excipients in Oral and injectable Formulations. Pharm. Res. 21: 201-230.
4. Cannon, J.B., and Long, M.A. Emulsions, Microemulsions, and Lipid-based Drug Delivery Systems for Drug Solubilization and Delivery, Part II: Oral Applications. In Water-Insoluble Drug Formulation, 2nd edition, Liu, R, Ed., CRC Press, Boca Raton FL (2008); p. 227-254.
5. Ranade, V. V., and Cannon, J. B. Drug Delivery Systems, 3rd edition, CRC Press, Boca Raton FL (2011); p. 215-242.
6. Sakai, K., Yoshimori, T., Obata, K., and Maeda, H. (2010). Design of self-microemulsifying drug delivery systems using a high-throughput formulation screening system. Drug Dev Ind Pharm. 36: 1245-1252.
7. Subramanian, N., Ray, S., Ghosal, S.K., Bhadra, R., and Moulik, S.P. (2004). Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol Pharm Bull. 27: 1993-1999. (Pubitemid 41701577)
8. Liu, Y., Chen, Z.Q., Zhang, X., Feng, N.P., Zhao, J.H., Wu, S., and Tan, R. (2010). An improved formulation screening and optimization method applied to the development of a self-microemulsifying drug delivery system. Chem Pharm Bull. 58: 16-22.
9. Rane, S.S., and Anderson, B.D. (2008). What determines drug solubility in lipid vehicles: Is it predictable? Adv. Drug Deliv. Rev. 60: 638-656.
10. Thi, T.D., Van Speybroeck, M., Barillaro, V., Martens, J., Annaert, P., Augustijns, P., Van Humbeeck, J., Vermant, J., and Van den Mooter, G. (2009) Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS. Eur J Pharm Sci. 38: 479-488.
11. Zhu, S., Hong, M., Liu, C,. and Pei, Y. (2009). Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm Dev Technol. 14: 642-429.
12. Mukherjee, T., and Plakogiannis, F.M. (2010). Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole. J Pharm Pharmacol. 62: 1112-1120.
13. Basalious, E.B., Shawky, N., and Badr-Eldin, S.M. (2010) SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 391: 203-211.
14. Mohsin, K., Long, M.A., and Pouton, C.W. (2009). Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci. 98: 3582-3595.
15. Cui, J., Yu, B., Zhao, Y., Zhu, W., Li, H., Lou, H., and Zhai, G. (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 371: 148-155.
16. Pouton, C.W. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, selfemulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 11 Suppl. 2 S93-S98.
17. Porter, C.J., Pouton, C.W., Cuine, J.F., and Charman WN. (2008). Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev., 60: 673-91.
18. Jantratid, E., Janssen, N., Chokshi, H., Tang, K., and Dressman, J.B. (2008). Designing biorelevant dissolution tests for lipid formulations: case example - lipid suspension of RZ-50. Eur J Pharm Biopharm., 69: 776-785.
19. Cuine, J.F., McEvoy, C.L., Charman, W.N., Pouton, C.W., Edwards, G.A., Benameur, H., and Porter, C.J. (2008). Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J Pharm Sci. 97: 995-1012. (Pubitemid 351293898)
20. Zangenberg, N.H., Mullertz, A., Kristensen, H.G., and Hovgaard, L. (2001). A dynamic in vitro lipolysis model. II: Evaluation of the model. Eur J Pharm Sci. 14: 237-244. (Pubitemid 32884320)
21. Fatouros, D.G., and Mullertz, A. (2008). In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin Drug Metab Toxicol. 4: 65-76.
22. Dahan, A., and Hoffman, A. (2008). Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release, 129: 1-10.
23. O'Driscoll, C.M., and Griffin, B.T. (2008). Biopharmaceutical challenges associated with drugs with low aqueous solubility - the potential impact of lipid-based formulations. Adv Drug Deliv Rev., 60: 617-624.
24. Araya, H., Tomita, M., and Hayashi, M. (2006). The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion III: the permeation mechanism of a poorly water soluble drug entrapped O/W microemulsion in rat isolated intestinal membrane by the Ussing chamber method. Drug Metab Pharmacokinet. 21: 45-53.
25. Liu, Y., Zhang, P., Feng, N., Zhang, X., Wu, S., and Zhao, J. (2009). Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 365: 136-42.
26. Fatouros, D.G., Karpf, D.M., Nielsen, F.S., and Mullertz, A. (2007). Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag. 3: 591-604. (Pubitemid 47496964)
27. Cannon, J.B. (2007). Chemical and Physical Stability Considerations for Lipid-Based Drug Formulations. Amer. Pharm. Rev. 10: 132-138.